產(chǎn)品名稱(chēng) | 毛細(xì)血管擴(kuò)張性共濟(jì)失調(diào)癥突變蛋白抗體 |
英文名稱(chēng) | Anti-ATM |
規(guī)格 | 0.1ml/100μg 0.2ml/200μg |
濃度 | 1mg/1ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱(chēng) Anti-ATM
中文名稱(chēng) 毛細(xì)血管擴(kuò)張性共濟(jì)失調(diào)癥突變蛋白抗體
濃 度 1mg/1ml
規(guī)格 0.1ml/100μg 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類(lèi)型 polyclonal
交叉反應(yīng) Human, Mouse, Rat
產(chǎn)品類(lèi)型 一抗
研究領(lǐng)域 心血管細(xì)胞生物免疫學(xué)細(xì)胞表面分子
蛋白分子量 predicted molecular weight: 370kDa
性 狀 Lyophilized or Liquid
免疫原 KLH conjugated synthetic peptide derived from human ATM (2681-2750aa)
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ)存液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
產(chǎn)品應(yīng)用 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year.
別 名 ataxia telangiectasia mutated; AT complementation group A; AT complementation group C; AT complementation group D; AT complementation group E; AT mutated; AT protein; AT1; ATA; Ataxia telangiectasia gene mutated in human beings; ATC; ATDC; ATE; ATM; DKFZp781A0353; Human phosphatidylinositol 3 kinase homolog; MGC74674; Serine protein kinase ATM; T cell prolymphocytic leukemia; TEL1; TPLL.
